MyndTec Inc.

—As of Sun 8 Nov 2026, 12:00 UTC

CSE:MYTCHealthcare

Country Canada

PE (Fwd) —

TSR 4Y CAGR (69.32%)

Div yield —

ROE —

Medical Devices

Beta (5Y) —

PE TTM —

TSR TTM (93.75%)

Mkt cap C$0.159M

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

$0.0054

—

7.80%

—

TTM

FYE 31 Dec CAD

FY2021

FY2022

FY2023

FY2024

FY2025E

FY2026E

Trend

10Y

Peers

0.111

Revenue$M

—

0.606

0.256

0.137

0.111

0.081

0.063

(43.12%)

—

(18.85)

Revenue growth%

—

(57.76)

(46.32)

(18.85)

(27.15)

(21.79)

(46.32)

—

4.36

Gross margin%

—

58.56

26.37

39.98

4.36

2.35

1.34

33.17

—

(1100.85)

Operating margin%

—

(448.46)

(795.10)

(1161.18)

(1100.85)

(100.00)

(947.97)

—

(1119.41)

Net margin%

—

(503.51)

(833.54)

(1255.05)

(1119.41)

(100.00)

(976.48)

—

P/E ratio (avg)x

—

EV/EBITx

—

(764.44)

FCF yield (avg)%

—

(12.49)

(6.34)

(50.59)

—

(12.49)

—

(844.27)

FCF margin%

—

(247.71)

(932.64)

(711.45)

(844.27)

(100.00)

(777.86)

—

0.754

FCF / Net incomex

—

0.492

1.119

0.567

0.754

—

0.661

—

ROIC%

—

Return on equity%

—

(397.81)

Return on assets%

—

(79.73)

(331.83)

(310.59)

(397.81)

(34.94)

(32.38)

(321.21)

—

(0.05)

EPS$

—

(0.14)

(0.10)

(0.07)

(0.05)

—

31.92

EPS growth%

—

28.06

25.89

31.92

93.49

21.79

28.06

—

(0.05)

Bookvalue per sh$

—

(0.16)

(0.04)

(0.05)

(0.06)

—

(0.04)

FCF per share$

—

(0.07)

(0.11)

(0.04)

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

31.88

Shares (diluted)M

—

21.84

21.23

23.15

24.61

◌24.61

4.07%

—

(6.32)

Buyback yield%

—

2.79

(9.06)

(6.32)

◌—

(6.32)

—

(0.374)

D/E ratiox

—

(0.587)

(0.266)

(0.495)

(0.374)

(0.351)

(0.355)

(0.435)

—

0.505

Enterprise value$M

—

19.28

15.68

2.205

0.550

0.613

(66.18%)

—

0.020

LT debt$M

—

0.595

0.240

—

0.020

0.047

(67.76%)

—

Peers (US$0.112M)

Cap (US$)

Imaging Dynamics…

0.256M

—

Aquarius Surgical…

0.195M

—

Verisante Technology…

0.091M

5.869x

Profusa, Inc.

0.324M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(58.33)

(37.94)

Own earn%

—

Sh yield%

(6.32)

Owners

Insiders/Inst%

40.13

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/4

Revenue growth years

0/3

EPS growth years

3/3

Dividend streakyrs

Op margin range%

−1161–−448

$1 testx

—

Incr. ROIC%

157

MyndTec Inc., a medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada, the United States, and Malaysia.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

$0.111M

(43.12%)

1.00×

Cost of revenue

$0.107M

(24.83%)

2.31×

Operating expenses

$1.232M

(26.25%)

2.18×

Asset mix

Trend

Other

62.54%

Cash and investments

37.46%

Reinvestment returns

No breakdown available